The impact of induction therapy HLA matching and T- and B-cell crossmatch on the long-term outcome of living donated renal transplantation.
Lumlertgul
D
D
Renal Division of Nephrology, Faculty of Medicine, Ching Mai University, Thailand.
Manoyos
A
A
Saikum
U
U
Chaovisitsaree
A
A
Boonkaew
S
S
Wongsawad
P
P
Bunnachak
D
D
Roachanapiwat
B
B
Wutikarn
S
S
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology*; D003429:Cross Reactions; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007163:Immunosorbent Techniques; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009679:Nuclear Family; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone